Medicines (MDCO) Short Interest Ratio & Short Volume → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free MDCO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Medicines Short Interest DataCurrent Short Volume25,180,000 sharesPrevious Short Volume23,050,000 sharesChange Vs. Previous Month+9.24%Dollar Volume Sold Short$2.12 billionShort Interest Ratio / Days to Cover6.8Last Record DateDecember 13, 2019Outstanding Shares79,723,000 sharesFloat Size76,800,000 sharesShort Percent of Float32.79%Today's Trading Volume0 sharesAverage Trading Volume9,546,600 sharesToday's Volume Vs. Average0% Short Selling Medicines ? Sign up to receive the latest short interest report for Medicines and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMDCO Short Interest Over TimeMDCO Days to Cover Over TimeMDCO Percentage of Float Shorted Over Time Ad InvestorPlaceProof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. Medicines Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/13/201925,180,000 shares $2.12 billion +9.2%32.8%6.8 $84.22 8/15/201921,001,900 shares $663.98 million -1.9%29.9%14 $31.62 MDCO Short Interest - Frequently Asked Questions What is Medicines' current short interest? Short interest is the volume of Medicines shares that have been sold short but have not yet been covered or closed out. As of December 13th, investors have sold 25,180,000 shares of MDCO short. 32.79% of Medicines' shares are currently sold short. Learn More on Medicines' current short interest. What is a good short interest ratio for Medicines? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MDCO shares currently have a short interest ratio of 7.0. Learn More on Medicines's short interest ratio. What is a good short interest percentage for Medicines? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 32.79% of Medicines' floating shares are currently sold short. Is Medicines' short interest increasing or decreasing? Medicines saw a increase in short interest during the month of December. As of December 13th, there was short interest totaling 25,180,000 shares, an increase of 9.2% from the previous total of 23,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Medicines' float size? Medicines currently has issued a total of 79,723,000 shares. Some of Medicines' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Medicines currently has a public float of 76,800,000 shares. How does Medicines' short interest compare to its competitors? 32.79% of Medicines' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Medicines: Jazz Pharmaceuticals plc (6.14%), Perrigo Company plc (2.88%), Corcept Therapeutics Incorporated (23.68%), Supernus Pharmaceuticals, Inc. (8.93%), Cytokinetics, Incorporated (13.91%), Elanco Animal Health Incorporated (3.14%), Blueprint Medicines Co. (6.94%), Intra-Cellular Therapies, Inc. (3.71%), Ionis Pharmaceuticals, Inc. (7.12%), Cerevel Therapeutics Holdings, Inc. (9.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: The Medicines Company ($2.12 billion), Genesee & Wyoming Inc ($433.11 million), Clovis Oncology ($306.74 million), Neogen Co. ($179.22 million), Jagged Peak Energy Inc ($168.19 million), Perdoceo Education Co. ($96.30 million), Arbor Realty Trust, Inc. ($89.67 million), Carbonite Inc ($65.84 million), Overstock.com, Inc. ($58.63 million), and Abeona Therapeutics Inc ($14.62 million). View all of the most shorted stocks. What does it mean to sell short Medicines stock? Short selling MDCO is an investing strategy that aims to generate trading profit from Medicines as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medicines? A short squeeze for Medicines occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MDCO, which in turn drives the price of the stock up even further. How often is Medicines' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MDCO, twice per month. The most recent reporting period available is December, 13 2019. More Short Interest Resources from MarketBeat Related Companies: Jazz Pharmaceuticals Short Squeeze Perrigo Short Squeeze Corcept Therapeutics Short Squeeze Supernus Pharmaceuticals Short Squeeze Cytokinetics Short Squeeze Elanco Animal Health Short Squeeze Blueprint Medicines Short Squeeze Intra-Cellular Therapies Short Squeeze Ionis Pharmaceuticals Short Squeeze Cerevel Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MDCO) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings